INDEMNITY AGREEMENTIndemnity Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of [•], 2021, by and between European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”) and (“Indemnitee”).
10,000,000 Units European Biotech Acquisition Corp. UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
EUROPEAN BIOTECH ACQUISITION CORP. Johannes Vermeerplein 9European Biotech Acquisition Corp. • March 4th, 2021 • Blank checks • New York
We are pleased to accept the offer LSP Sponsor EBAC B.V. (the “Subscriber” or “you”) has made to subscribe for and purchase 2,875,000 Class B ordinary shares (the “Shares”), $0.0001 par value per share (the “Class B Ordinary Shares” together with all other classes of Company (as defined below) ordinary shares, the “Ordinary Shares”), up to 375,000 Shares of which are subject to complete or partial forfeiture by you if the underwriters of the initial public offering (“IPO”) of European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), do not fully exercise their over-allotment option (the “Over-allotment Option”). The terms (this “Agreement”) on which the Company is willing to sell the Shares to the Subscriber, and the Company and the Subscriber’s agreements regarding such Shares, are as follows:
REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENTRegistration and Shareholder Rights Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
THIS REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2021, is made and entered into by and among European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), LSP Sponsor EBAC B.V., a Dutch limited liability company (the “Sponsor”), and the undersigned parties listed under Holder on the signature page hereto (each such party, together with the Sponsor and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, a “Holder” and collectively the “Holders”).
European Biotech Acquisition Corp. Johannes Vermeerplein 9 Credit Suisse Securities (USA) LLC Eleven Madison Avenue New York, New York 10010-3629 Kempen & Co. U.S.A., Inc. New York NY 10022 United States of AmericaLetter Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and among European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), Credit Suisse Securities (USA) LLC and Kempen & Co. U.S.A., Inc., as representatives (the “Representatives”) of the several underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”) of 10,000,000 of the Company’s units (including 1,500,000 units that may be purchased pursuant to the Underwriters’ option to purchase additional units, the “Units”), each comprised of one of the Company’s Class A ordinary shares, par value $0.0001 per share (the “Ordinary Shares”), and one-third of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units w
WARRANT AGREEMENT EUROPEAN BIOTECH ACQUISITION CORP. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY Dated [●], 2021Warrant Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
THIS WARRANT AGREEMENT (this “Agreement”), dated [●], 2021, is by and between European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (in such capacity, the “Warrant Agent”).
INVESTMENT MANAGEMENT TRUST AGREEMENTInvestment Management Trust Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
This Investment Management Trust Agreement (this “Agreement”) is made effective as of [●], 2021 by and between European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Trustee”).
PRIVATE PLACEMENT UNITS PURCHASE AGREEMENTPrivate Placement Units Purchase Agreement • March 4th, 2021 • European Biotech Acquisition Corp. • Blank checks • New York
THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), dated as of [●], 2021, is entered into by and between European Biotech Acquisition Corp., a Cayman Islands exempted company (the “Company”), and LSP Sponsor EBAC B.V., a Dutch limited liability company (the “Purchaser”).
European Biotech Acquisition Corp. Johannes Vermeerplein 9European Biotech Acquisition Corp. • March 4th, 2021 • Blank checks
